Abstract
Recent studies indicate that excessive production of oxidants plays a role in the pathogenesis of glomerular injury leading to proteinuria in patients with minimal-change nephrotic syndrome (MCNS). The novel free radical scavenger, edaravone (EDA), which was recently developed in Japan, is currently used in patients with stroke. We studied whether this new agent would be beneficial in patients with MCNS by its antioxidant activity and examined its effect on proteinuria in nephrosis induced by puromycin-aminonucleoside (PAN) in rats. Nineteen Wistar-Kyoto rats injected with PAN were assigned to four groups: group 1, without EDA (n=4); group 2, concomitant EDA injection from 1 day prior to PAN administration (n=5); group 3, concomitant EDA injection from 1 day after PAN administration (n=5); group 4, concomitant EDA injection from 3 days after PAN administration (n=5). Daily urinary excretions of protein and 8-hydroxy-2’-deoxyguanosine (8-OHdG), a new sensitive marker of oxidative DNA damage in vivo, were measured in each group from the 1st to the 30th day after PAN injection. In group 1 proteinuria developed from the 5th day and reached the peak level on the 9th day. In groups 2, 3, and 4 proteinuria did not appear until the 6th day. The excretions in urinary protein and 8-OHdG were significantly lower in groups 2, 3, and 4 than group 1 on days 5, 9, and 25. In conclusion, EDA could delay and ameliorate the urinary protein excretion in accordance with the urinary 8-OHdG excretion in PAN-induced nephrosis.
Similar content being viewed by others
References
Shalhoub RJ (1974) Pathogenesis of lipid nephrosis: a disorder of T-cell function. Lancet II:556–560
Fiser RT, Arnold WC, Charlton RK, steele RW, Childress SH, Shirkey B (1991) T-lymphocyte subsets in nephrotic syndrome. Kidney Int 40:913–916
Nunez-Roldan A, Villechenous E, Fernandez-Andrade C, Martin-Govantes J (1982) Increased HLA-DR7 and decreased DR2 in steroid-responsive nephrotic syndrome. N Engl J Med 306:366–367
Diamond JR (1992) The role of reactive oxygen species in animal models of glomerular disease. Am J Kidney Dis 19:292–300
Raats CJI, Bakker MAH, Van den Born J, Berden JHM (1997) Hydroxyl radicals depolymerize glomerular heparin sulfate in vitro and in experimental nephrotic syndrome. J Biol Chem 272:26734–26741
Thakur V, Walker PD, Shah SV (1988) Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria. Kidney Int 34:494–499
Kinra S, Rath B, Kabi BC (2000) Indirect quantification of lipid peroxidation in steroid responsive nephrotic syndrome. Arch Dis Child 82:76–78
Turi S, Nemeth I, Torkos A, Saghy L, Varga I, Matkovics B, Nagy J (1997) Oxidative stress and antioxidant defense mechanism in glomerular diseases. Free Radic Biol Med 22:161–168
Fydryk J, Jacobson E, Kurzawska O, Malecka G, Gonet B, Urasinski T, Brodkiewicz A, Bukowska H (1998) Antioxidant status of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 12:751–754
Guidet BR, Sudhir SV (1989) In vivo generation of hydrogen peroxide by rat kidney cortex and glomeruli. Am J Physiol 256:F158–F164
Baud L, Ardaillou R (1986) Reactive oxygen spiecies: production and role in the kidney. Am J Physiol 251:F765–F776
Yoshioka T, Ichikawa I, Fogo A (1991) Reactive oxygen metabolites cause massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality. J Am Soc Nephrol 2:902–912
Doi K, Suzuki Y, Nakao A, Fujita T, Noiri E (2004) Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney. Kidney Int 65:1714–1723
Edaravone Acute Infarction Study Group (2003) Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 15:222–229
Lannigan R, Kark R, Pollak VE (1962) The effect of a single intravenous injection of aminonucleoside of puromycin on the rat kidney: a-light and electron-microscope study. J Pathol Bacteriol 83:357–362
Diamond JR, Bonventre JV, Karnovsky MJ (1986) A role for oxygen free radicals in aminonucleoside nephrosis. Kidney Int 29:478–483
Shigenaga MK, Ames BN (1991) Assays for 8-hydroxy-2’-deoxyguanosine: a biomarker of in vivo oxidative DNA damage. Free Radic Biol Med 10:211–216
Fraga CG, Shigenaga MK, Park JW, Degan P, Ames BN (1990) Oxidative damage to DNA during aging: 8-hydroxy-2’-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 87:4533–4537
Toyokuni S, Tanaka T, Hattori Y, Nishiyama Y, Yoshida A, Uchida K, Hiai H, Ochi H, Osawa T (1997) Quantitative immunohistochemical determination of 8-hydroxy-2’-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 76:365–374
Saito S, Yamauchi H, Hasui Y, Kurashige J, Ochi H, Yoshida K (2000) Quantitive determination of 8-hydroxy-2’-deoxyguanosine (8-OH-dg) by using ELISA. Res Commun Mol Pathol Pharmacol 107:39–44
Fawcett JP, Jiang R, Walker RJ (1994) Time course of lipid peroxidation in puromycin aminonucleoside-induced nephropathy. Res Commun Mol Pathol Pharmacol 86:227–234
Ricardo SD, Bertram JF, Ryan GB (1994) Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats. J Am Soc Nephrol 4:1974–1986
Abe K, Yuki S, Kogure K (1988) Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19:480–485
Watanabe T, Yuki S, Egawa M, Nishi H (1994) Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 268:1597–1604
Satoh M, Kashihara N, Fujimoto S, Horike H, Tokura T, Namikoshi T, Sasaki T, Makino H (2003) A novel free radical scavenger, edaravone, protects against Cisplatin-induced acute renal damage in vitro and in vivo. J Pharmacol Exp Ther 305:1183–1190
Kono H, Asakawa M, Fujii H, Maki A, Amemiya H, Yamamoto M, Matsuda M, Matsumoto Y (2003) Edaravone, a novel free radical scavenger, prevents liver injury and mortality in rats administered endotoxin. J Pharmacol Exp Ther 307:74–82
Minhaz U, Tanaka M, Tsukamoto H, Watanabe K, Koide S, Shohtsu A, Nakazawa H (1996) Effect of MCI-186 on postischemic reperfusion injury in isolated rat heart. Free Radic Res 24:361–367
Kawachj H, Koike H, Kurihara H, Sakai T, Shimizu F (2003) Cloning of rat homologue of podocin: expression in proteinuric states and in developing glomeruli. J Am Soc Nephrol 14:46–56
Lee YK, Kwon T, Kim DJ, Huh W, Kim YG, Oh HY, Kawachi H (2004) Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis. Nephrol Dial Transplant 19:2981–2986
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Someya, T., Kaneko, K., Yamada, T. et al. Effect of a novel free radical scavenger, edaravone, on puromycin aminonucleoside induced nephrosis in rats. Pediatr Nephrol 20, 1430–1434 (2005). https://doi.org/10.1007/s00467-005-1959-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-005-1959-9